| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9163741 | Chest | 2005 | 10 Pages |
Abstract
Hypoxia combined with anemia increased the risk for death in SARS patients. Unless ribavirin can be shown to be effective against SARS-coronavirus, the risk of anemia posed by this drug argues against its use in SARS patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chiou MS, Liu MD, Buttrey MD, Kuo MD, Liu MS, Kuo MD, FCCP, Lu MD, PhD,